Owlet Inc Dossier
Qualitative Analysis
Business overview
Owlet, Inc. (NYSE: OWLT) is a pioneer and leading pediatric health platform specializing in smart infant monitoring technology. Founded in 2012, the company's mission is to empower parents with real-time, actionable health data and insights to provide peace of mind and support infant well-being. Owlet's product ecosystem includes the FDA-cleared Dream Sock (a wearable infant health monitor tracking pulse rate, oxygen levels, and sleep patterns), BabySat (a prescription-only, medical-grade pulse oximeter), and integrated video monitoring systems like the Owlet Cam. By combining advanced medical-grade oximetry with consumer-friendly design, Owlet bridges the critical gap between hospital care and home monitoring.
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Expanding the footprint of the FDA-cleared Dream Sock globally, including recent launches in Australia, New Zealand, the UK, and Ireland.
Expected impact: Drives top-line hardware sales and establishes a larger base of connected devices for subscription attachment.
Transitioning the business model from one-time device sales to a comprehensive pediatric health platform by growing the recurring subscription base.
Expected impact: Expands gross margins significantly due to the 90%+ gross margin profile of software subscriptions compared to hardware.
Securing partnerships with Durable Medical Equipment (DME) providers to place prescription-only BabySat and consumer Dream Sock on insurance-reimbursable pathways.
Expected impact: Lowers customer acquisition costs and expands the addressable market to insured, Medicaid, and TRICARE families.
Partnering with webAI to build secure, private, and personalized pediatric health intelligence on Owlet's proprietary dataset of over 30 billion sleep hours.
Expected impact: Accelerates the development of AI-driven sleep analytics and personalized insights to drive subscriber retention and platform value.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Enables Owlet to train private, enterprise-grade AI models on its proprietary pediatric dataset to deliver secure, personalized health and sleep insights.
Expands the clinical distribution footprint of the prescription pulse oximeter, BabySat, across key U.S. regions through established pediatric respiratory pathways.
Provides nationwide insurance-supported access to BabySat and Dream Sock, leveraging 1 Natural Way's digital-first platform and commercial, Medicaid, and TRICARE networks.
Integrates Blue SDK Bluetooth software stack into the new Dream Sight camera baby monitor to deliver secure, reliable, and seamless connectivity.